ReNeuron Group PLC (RQE)

London
31.75
-2.75(-7.97%)
  • Volume:
    946,270
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    31.75 - 31.75

RQE Overview

Prev. Close
34.5
Day's Range
31.75-31.75
Revenue
280K
Open
34.5
52 wk Range
31.5-153.78
EPS
-0.19
Volume
946,270
Market Cap
18.12M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
274,516
P/E Ratio
-
Beta
1.9
1-Year Change
-74.29%
Shares Outstanding
57,063,623
Next Earnings Date
02 Mar 2022
What is your sentiment on ReNeuron Group PLC?
or
Market is currently closed. Voting is open during market hours.

ReNeuron Group PLC Company Profile

Employees
0

ReNeuron Group plc is a United Kingdom-based cell-based therapeutics company. The Company develops allogeneic stem cell technology platforms, stem cell derived exosomes and induced pluripotent stem cells. The Company's products are allogeneic. Its CTX stem cell therapy is used for the treatment of patients left disabled by the effects of a stroke. Its human retinal progenitor cells (hRPC) stem cell candidate is used for the treatment of retinitis pigmentosa (RP). The Company's exosomes nanomedicine platform focuses on generating early pre-clinical data in cancer. Its ReNcell Products include ReNcellVM and ReNcellCX cell lines. It is engaged in Phase II clinical trial of CTX cells for stroke disability. It is engaged in Phase I clinical trial of CTX cells for Critical Limb Ischaemia. It is engaged in Phase I clinical trial of hRPC stem cell candidate.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.